GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Float Percentage Of Total Shares Outstanding

Hamlet BioPharma AB publ (XSAT:HAMLET B) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jul. 06, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hamlet BioPharma AB publ's float shares is 0.00 Mil. Hamlet BioPharma AB publ's total shares outstanding is 177.69 Mil. Hamlet BioPharma AB publ's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hamlet BioPharma AB publ's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hamlet BioPharma AB publ's Institutional Ownership is 0.00%.


Hamlet BioPharma AB publ Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Hamlet BioPharma AB publ's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/177.69
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ Business Description

Industry
Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines